Skip to main content
Clinical Trials/NCT03507634
NCT03507634
Completed
Not Applicable

Opioid Free Anesthesia in Bariatric Surgery: A Prospective, Double-blinded, Randomized, Controlled Clinical Trial

Lebanese American University1 site in 1 country80 target enrollmentApril 11, 2018

Overview

Phase
Not Applicable
Intervention
Opioid based anesthesia Fentanyl and Remifentanyl
Conditions
Opioid Use
Sponsor
Lebanese American University
Enrollment
80
Locations
1
Primary Endpoint
Postoperative pain score for 48 hours
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

This study compares the intraoperative opioid free anesthesia approach in laparoscopic bariatric surgery to a conventional opioid- based anesthesia. Half of participants will receive opioid free anesthesia with dexmedetomidine, lidocaine and ketamine while the other half will receive opioid based anesthesia with fentanyl, remi-fentanyl and ketamine

Detailed Description

Since optimal analgesia for the obese patients undergoing bariatric surgeries has always been challenging, and knowing the comorbidities and physiological changes in this population, use of opioid-sparing agents during anesthesia has attracted substantial research.the use of opioids in the perioperative period in obese patients is associated with an increased risk of complications . They are especially more sensitive to the respiratory depressant effect of opioids , thus any analgesic alternative without further compromising airway tone would be a desirable choice. Dexmedetomidine is a selective alpha-two adrenergic receptor agonist that has antinociceptive, analgesic and sedative properties, without compromising airway tone and reflexes . Lidocaine, a local anesthetic that has been shown to be an effective multimodal strategy to minimize postoperative pain was evaluated in one study involving obese patients undergoing bariatric surgery. Its usage was associated with an improved quality of recovery compared to placebo .

Registry
clinicaltrials.gov
Start Date
April 11, 2018
End Date
June 30, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hanane Barakat

MD

Lebanese American University

Eligibility Criteria

Inclusion Criteria

  • Age group: 18-65 years old
  • American Society of Anesthesiologists (ASA )class I and II
  • Indicated laparoscopic bariatric surgery

Exclusion Criteria

  • Renal, hepatic or cardiac insufficiency
  • Positive pregnancy test
  • Alcohol or drug abuse
  • Psychiatric disease
  • History of chronic pain
  • Allergy or contraindication to any of the study drugs

Arms & Interventions

Opioid Based Anesthesia

General anesthesia will be induced using Propofol , fentanyl , and Rocuronium . Ketamine will be administered on induction of anesthesia with the same dose to be repeated every hour. Anesthesia will be maintained with Remi-fentanyl and Sevoflurane.

Intervention: Opioid based anesthesia Fentanyl and Remifentanyl

Opioid Free Anesthesia

General anesthesia will be induced using dexmedetomidine and lidocaine started 10 minutes before induction, Propofol and Rocuronium . Ketamine will be administered on induction of anesthesia with the same dose to be repeated every hour. Anesthesia will be maintained with IV infusion of dexmedetomidine , lidocaine and Sevoflurane.

Intervention: Opioid free Anesthesia dexmedetomidine and lidocaine

Outcomes

Primary Outcomes

Postoperative pain score for 48 hours

Time Frame: 48 hours postoperative

Measure the pain score using the Visual Analogue Scale (VAS), The Visual Analogue Scale (VAS) consists of a straight line with the endpoints defining extreme limits such as 'no pain at all' and 'pain as bad as it could be' The patient is asked to mark his pain level on the line between the two endpoints. The distance between 'no pain at all' and the mark then defines the subject's pain. The score ranges from 0 to 100 mm. A higher score indicates greater pain intensity. The distribution pain is the following:no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm).Postoperative pain will be measured using Verbal Analogue Scale (VAS) at 0, 1, 2, 4, 6, 12, 18, and 24 and every 6 hours up to 48 hours post surgery.

Secondary Outcomes

  • Postoperative morphine consumption at the surgical ward for 48 hours(48 hours postoperative)
  • Postoperative morphine Side effects: Sedation score .for 48 hours(48 hours postoperative)
  • Postoperative morphine Side effects:Respiratory depression for 48 hours(48 hours postoperative)
  • Postoperative morphine consumption at the PACU (Post Anesthesia Care Unit)(2 hours postoperative)
  • Postoperative morphine Side effects: Nausea vomiting for 48 hours(48 hours postoperative)
  • Postoperative morphine Side effects: Itching for 48 hours(48 hours postoperative)

Study Sites (1)

Loading locations...

Similar Trials